Gastrointestinal Neuroendocrine Pancreatic Tumor
1 clinical trials · Condition
◉ Watch Gastrointestinal Neuroendocrine Pancreatic Tumor
| Record | Firm | Date |
|---|---|---|
| A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) (NCT06505395) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-07-30 |
Track Gastrointestinal Neuroendocrine Pancreatic Tumor automatically
Every clearance here is in the API, with alerts when new ones post.